ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,040,000 | +30.0% | 1,097,765 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,107,000 | -23.7% | 1,097,765 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,073,000 | +40.9% | 1,097,765 | +9.4% | 0.00% | 0.0% |
| Q4 2017 | $2,891,000 | -83.4% | 1,003,747 | -74.1% | 0.00% | -81.8% |
| Q3 2017 | $17,406,000 | -16.2% | 3,876,709 | -14.4% | 0.01% | -21.4% |
| Q2 2017 | $20,778,000 | – | 4,526,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |